Mean Platelet Volume Is a Poor Prognostic Factor in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

被引:0
|
作者
Senturk, Mustafa [1 ]
Ince, Volkan [1 ]
Ureyen, Orhan [2 ]
Eyvaz, Kemal [3 ]
Isik, Burak [1 ]
Carr, Brian, I [1 ]
Yilmaz, Sezai [1 ]
机构
[1] Inonu Univ, Liver Transplant Inst, Dept Surg, Malatya, Turkiye
[2] Hlth Sci Univ, Izmir Bozyaka Training & Res Hosp, Dept Gen Surg, Izmir, Turkiye
[3] Univ Hlth Sci, Antalya Educ & Res Hosp, Dept Gen Surg, Antalya, Turkiye
来源
TURKISH JOURNAL OF GASTROENTEROLOGY | 2025年 / 36卷 / 03期
关键词
MPV; hepatocellular cancer; transplantation;
D O I
10.5152/tjg.2025.24540
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Mean platelet volume (MPV) reflects platelet activation. Platelets have an important role in tumor progression and metastasis. In this study, we wanted to investigate the effect of MPV on survival in patients undergoing liver transplantation (LT) for hepatocellular carcinoma (HCC). Materials and Methods: All data of 376 patients who underwent LT and pathologically diagnosed with HCC were analyzed. Bydetermin- ing the cut-off of MPV (10.2 fL), 2 groups with high and low MPV were formed. The groups were compared within themselves. Factors affecting survival were determined by univariate and multivariate analysis. Results: When the groups were compared, patients with low MPV had significantly higher platelet counts, larger tumor sizes, lower BMI, and higher recurrence rates. In multivariate analysis, GGT >104, AFP >200 mu g/L, largest tumor diameter >5 cm, and lower MPV were found to be independent risk factors that affected the prognosis. Tumor-free survival was significantly worse in the lower MPV group (P = .002). Conclusion: Pre-transplant low MPV maybe useful in predicting poor prognosis and a high rate of tumor recurrence in patients with HCC after liver transplantation.
引用
收藏
页数:71
相关论文
共 50 条
  • [11] Sarcopenia in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
    Garcia, Catherine
    Acosta, Luis
    Galuppo, Roberto
    Villacorta, Evelyn
    Dugan, Adam
    Castellanos, Ana
    Lee, James
    Gedaly, Roberto
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 80 - 81
  • [12] Mean Platelet Volume and Unresectable Hepatocellular Carcinoma
    Bakshi, Satvinder Singh
    LIVER CANCER, 2020, 9 (01) : 105 - 106
  • [13] GIV is a promising novel poor prognostic factor in liver hepatocellular carcinoma
    Zou, Zhenzhen
    Sun, Yibin
    Wang, Lin
    Ma, Sai
    Sun, Chunrong
    Zhou, Yu
    Yang, Guorong
    MEDICINE, 2022, 101 (32) : E29645
  • [14] Mean platelet volume/platelet count ratio in hepatocellular carcinoma
    Cho, Sun Young
    Yang, John Jeongseok
    You, Eunkyoung
    Kim, Byung-Ho
    Shim, Jaejun
    Lee, Hee Joo
    Lee, Woo-In
    Suh, Jin-Tae
    Park, Tae Sung
    PLATELETS, 2013, 24 (05) : 375 - 377
  • [15] Predictors of survival in patients undergoing liver transplantation for hepatocellular carcinoma
    Deenadayalu, VP
    Tector, AJ
    Agarwal, D
    Lumeng, L
    Chalasani, N
    Liangpunsakul, S
    Fridell, J
    Vianna, RM
    Qi, R
    Kwo, PY
    GASTROENTEROLOGY, 2005, 128 (04) : A758 - A758
  • [16] Intrahepatic cholangiocarcinoma in patients undergoing liver transplantation for hepatocellular carcinoma
    Dayangac, M.
    Bozkurt, B.
    Gurcan, Inan N.
    Dogusoy, Bulbul G.
    Tokat, Y.
    TRANSPLANTATION, 2018, 102 : 275 - 276
  • [17] Impact of Hypothyroidism on Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation
    Salman, Ahmed
    Aon, Mohamed
    Hussein, Amr
    Salman, Mohamed
    Tourky, Mohamed
    Mahmoud, Ahmed
    Aljarad, Feras
    Elkaseer, Mohamed
    Shaaban, Hossam El-Din
    Moustafa, Ahmed
    El-Mikkawy, Ahmed
    Gaballa, Nahla
    Abdallah, Heba
    Rashed, Zaky Ftouh Zaky
    Elkassar, Hesham
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 5711 - 5718
  • [18] Predicting Outcomes of Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
    Firl, Daniel J.
    Sasaki, Kazunari
    Aucejo, Federico N.
    GASTROENTEROLOGY, 2018, 154 (06) : 1856 - 1857
  • [19] Living donor liver transplantation for hepatocellular carcinoma: is surgeon a prognostic factor?
    Rajeev Sharma
    Durgatosh Pandey
    Indian Journal of Gastroenterology, 2009, 28 (2) : 78 - 79
  • [20] Hemorrhage of brain metastasis is a poor prognostic factor in hepatocellular carcinoma patients
    Lin, Yan
    Huang, Shi-Ting
    Jiang, Yan-Ming
    Pan, Xin-Bin
    ONCOTARGET, 2017, 8 (54) : 93245 - 93250